UGT1A4 and breast cancer: Consequently, polymorphisms in genes implicated in BC pathogenesis, such as those involved in tamoxifen pharmacogenetics, such as the UGT1A4 and UGT2B7 genes, are frequent targets of BC research [6, 7].